TY - JOUR
T1 - Does DNCB therapy potentiate epicutaneous sensitization to non‐related contact allergens?
AU - DE GROOT, A. C.
AU - NATER, J. P.
AU - BLEUMINK, E.
AU - DE JONG, M. C. J. M.
PY - 1981
Y1 - 1981
N2 - Nineteen patients suffering from alopecia areata were treated weekly with both 2,4‐dinitro‐chlorobenzene (DNCB) and dithranol applied to separate areas on the scalp. During treatment seven patients developed contact hypersensitivity to dithranol. Our findings indicate that repeated topical application of DNCB may increase the susceptibility of the treated individual to contact allergens. This would constitute a serious draw‐back in the acceptibility of DNCB immunotherapy. Copyright © 1981, Wiley Blackwell. All rights reserved
AB - Nineteen patients suffering from alopecia areata were treated weekly with both 2,4‐dinitro‐chlorobenzene (DNCB) and dithranol applied to separate areas on the scalp. During treatment seven patients developed contact hypersensitivity to dithranol. Our findings indicate that repeated topical application of DNCB may increase the susceptibility of the treated individual to contact allergens. This would constitute a serious draw‐back in the acceptibility of DNCB immunotherapy. Copyright © 1981, Wiley Blackwell. All rights reserved
UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=0019418902&origin=inward
UR - https://www.ncbi.nlm.nih.gov/pubmed/6455221
U2 - https://doi.org/10.1111/j.1365-2230.1981.tb02280.x
DO - https://doi.org/10.1111/j.1365-2230.1981.tb02280.x
M3 - Article
C2 - 6455221
SN - 0307-6938
VL - 6
SP - 139
EP - 144
JO - Clinical and experimental dermatology
JF - Clinical and experimental dermatology
IS - 2
ER -